Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02244918 · ClinicalTrials.gov registry record · Phase 4
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
A Phase 4 study of Smoking Cessation, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 278
- Enrollment target
- 2
- Study locations
NCT02244918 is a Phase 4 study of Smoking Cessation that has completed, run by University of Kansas Medical Center. The registered enrollment target is 278 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (41% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02244918, a Phase 4 study of Smoking Cessation, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 278 participants
- Enrollment target
- 2
- Study locations
Study Summary
The researchers are testing if counseling alone or counseling plus over-the-counter nicotine replacement therapies (NRT), like the patch,gum, or lozenge, helps African American non-daily smokers quit smoking.
Conditions Studied
Interventions
- BEHAVIORAL Smoking Cessation Counseling
- DRUG Nicotine Replacement Therapy
Study Locations (2)
Kansas
- University of Kansas Medical Center - Kansas City
Missouri
- Swope Health Central - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2015-05 |
| Est. Completion | 2018-03-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02244918
The ClinicalTrials.gov registry entry for NCT02244918 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 278 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (41% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Smoking Cessation Counseling is the first listed.
NCT02244918 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kansas, Missouri.
Frequently Asked Questions
What is clinical trial NCT02244918 about?
NCT02244918 is a clinical study titled "Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers". The researchers are testing if counseling alone or counseling plus over-the-counter nicotine replacement therapies (NRT), like the patch,gum, or lozenge, helps African American non-daily smokers quit smoking.
What is the current status of trial NCT02244918?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 278 participants. The study started on 2015-05. Estimated completion is 2018-03-15.
What conditions does trial NCT02244918 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT02244918?
The interventions under investigation include: Smoking Cessation Counseling (BEHAVIORAL), Nicotine Replacement Therapy (DRUG).
Who is sponsoring clinical trial NCT02244918?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02244918 being conducted?
This trial has 2 study locations across Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.